Alnylam Pharmaceuticals Inc ALNY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:02 PM EDT
137.40UNCH (UNCH)
Volume
70,034
Close
137.40quote price arrow down-1.48 (-1.07%)
Volume
414,403
52 week range
119.29 - 178.41

...

Loading . . .
  • Open138.34
  • Day High140.82
  • Day Low136.09
  • Prev Close138.88
  • 52 Week High178.41
  • 52 Week High Date01/26/21
  • 52 Week Low119.29
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap16.12B
  • Shares Out117.32M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change5.72

KEY STATS

  • Open138.34
  • Day High140.82
  • Day Low136.09
  • Prev Close138.88
  • 52 Week High178.41
  • 52 Week High Date01/26/21
  • 52 Week Low119.29
  • 52 Week Low Date10/30/20
  • Market Cap16.12B
  • Shares Out117.32M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change5.72

RATIOS/PROFITABILITY

  • EPS (TTM)-7.45
  • P/E (TTM)-18.43
  • Fwd P/E (NTM)-21.49
  • EBITDA (MRQ)-793.666M
  • ROE (MRQ)-69.92%
  • Revenue (MRQ)492.85M
  • Gross Margin (MRQ)84.16%
  • Net Margin (MRQ)-174.15%
  • Debt To Equity (MRQ)18.82%

EVENTS

  • Earnings Date04/29/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Alnylam Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The Company is focused on the use of its N-acetylgalactosamine (GalNAc)-conjugate platform for delivery of small interfering RNAs (siRNAs). Its pipeline of investigational RNAi therapeutics focuses on three Strategic Therapeutic Areas (STArs): Genetic Medicines, with multiple...
Michael Bonney
Chairman
John Maraganore Ph.D.
Chief Executive Officer
Yvonne Greenstreet
President
Jeffrey Poulton
Chief Financial Officer
Laurie Keating
Executive Vice President
Address
675 W Kendall St
Cambridge, MA
02142-1168
United States

Top Peers

SYMBOLLASTCHG%CHG
NVAX
Novavax Inc
221.50-5.85-2.57%
GH
Guardant Health Inc
152.92-5.58-3.52%
NTRA
Natera Inc
104.93-2.03-1.89%
NVZMY
Novozymes A/S
65.56-0.01-0.02%
RARE
Ultragenyx Pharmaceutical Inc
105.39-3.33-3.06%